BRAF-inhibitors are powerful drugs and are known to be crucial for melanoma patients. The BRAF's protein power can be turned off by the inhibitors, resulting in a spur of cancer cell growth. Yet these inhibitors often work for only a year or less. Scientists know some of the DNA mutations that cause the drug resistance, but scientists have not been able to determine the underlying cause of the resistance in as many as a third of these patients. As a result, identifying ...
Read More
You have just read an article categorized health
titled Study of Skin Cancer Patients Resistant to Leading Therapy.
Written by:
editor -
Tuesday, February 24, 2015
There are currently no comments for "Study of Skin Cancer Patients Resistant to Leading Therapy"
Post a Comment